BIBLIOGRAFIA
Alphaugh ML., Tomlinson JS., Kasraeian S., Barsky SH. (2002) Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma. Oncogene. Vol.21, No.22, pp.3631-3643
Anderson JM. (1980) Inflammatory carcinomas of the breast. Ann R Coll
Surg Engl. Vol.62, No.3, pp.195-199
Anderson W. F., Chu Kenneth C., Chang Shine (2003) Inflammatory breast carcinoma and non inflammatory locally advanced breast carcinoma: distinct clinicopathologic entities? Journal of clinical oncology. Vol.21, pp.2254-2259
Arriagada R., Mouriesse H., Spielmann M., Mezlini A., Oudinot P., Le Chevalier T., Cuvier C., Fontaine F., Travagli JP., May-Levin F., et al. (1990) Alternating radiotherapy and chemotherapy in non-metastatic inflammatory breast cancer. Int J Radiat Oncol Biol Phys. Vol.19, No.5, pp.1207-1210
Aziz Syed A., Pervez Shahid, Khan Shaista, Kayani Naila, Azam Syid I., Rahbar Mohammad H. (2001) Case control study of prognostic markers and disease outcome in inflammatory carcinoma breast: a unique clinical experience. The breast journal. Vol.7, No.6, pp.398-404
Bilbao JI., Rebollo J., Longo JM., Mansilla F., Munoz-Galindo L., Vieitez JM. (1992) Neoadjuvant intra-arterial chemotherapy in inflammatory carcinoma of the breast. Br J radiol. Vol.65, No.771, pp.248-251
Brown RS., Leung JY., Fisher SJ., Frey KA., Ethier SP., Wahl RL. (1995) Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important? J nucl med. Vol.36, No.10, pp.1854-1861
Brun B., Otmezguine Y., Feuilhade F., Julen M., Lebourgeois JP., Calitchi E., Roucayrol AM., Ganem G., Huart J., Pierquin B. (1998) Treatment of inflammatory breast cancer with combination chemotherapy and mastectomy versus breast conservation. Cancer. Vol.61, No.6, pp.1096-1103
Castagnaro M., Casalone C., Bozzetta E., De Maria R., Biolatti B., Caramelli M. (1998) Tumour grading and the one-year post surgical prognosis in feline mammary carcinomas. J.Comp. Phat. Vol.119, pp.263-275
Chang S., Parker S. L., Pham T., Buzdar A. U., Hursting S. D. (1998) Inflammatory breast carcinoma incidence and survival. Cancer. Vol. 82, No.12, pp.2366-2372
Chang S., Chang CC., Chang TJ., Wong Min-Liang (2005) Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumours: 79 cases (1998-2002). JAVMA. Vol.227, No.10, pp.1625-1629
Charafe-Jauffret E., Tarpin C., Baurdou VJ., Bertucci F. Ginestier C., Braud AC., Pui Geneix J., Hassoun J., Birnbaum D., Jacquemier J., Viens P. (2004) Immunophenotypic analysis of inflammatory breast cancers: identification of an “inflammatory signature”. J Pathol. Vol.202, No.3, pp.265-273
Charpin C., Bergeret D., Garcia S., Andrac L., Martini F., Horschowski N., Choux R., Lavaut MN. (1998) ELAM selectin expression in breast carcinomas detected by automated and quantitative immunohistochemical assays. Int J Oncol. Vol.12, No.5, pp.1041-1048 Choi W. WL., Lewis Melinda M, Lawson Diane, Qiqin Yin-Goen, Birdsong George G., Cotsonis George A., Cohen Cynthia, Young A. N. (2005) Angiogenic and lynphangiogenic microvessel density in breast carcinoma: correlation with clinicophatologic parameters and VEGF-family gene expression. Modern pathology. Vol.18, pp.143-152
Correale M., Paradiso A. Quaranta M. Fattori prognostico-predittivi nel carcinoma della mammela. Caleidoscopio. Rivista mensile di Medicina anno 20, numero 157
Dahlbeck SW., Donnelly JF., Theriault RL., (1995) Differentiating inflammatory breast cancer from acute mastitis. Am Fam Physician. Vol.52, No.3, pp.929-934
De Las Mulas J. M., Millán Y., Dios R. (2005) A prospective analysis of immunohistochemically determined estrogen receptor α and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog. Vet. Pathol. Vol.42, pp.200-212 De Las Mulas J. M., Millán Y., Ordas J., Fernández-Soria V., Ramón y Cajal S. (2003) Oncogene HER-2 in canine mammary gland carcinomas.
Breast cancer research and Treatment. Vol.80, pp.363-367
Dershaw DD., Moore M. P., Liberman L., Beth M. Deutch (1994) Inflammatory breast carcinoma: mammographic findings. Radiology. Vol.190, pp.831-834
Davies G., Martin LA., Sacks N., Dowsett M. (2002) Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention. Ann Oncol. Vol.13, No.5, pp.669-678 Donegan WL., Padrta B. (1990) Combined therapy for inflammatory breast cancer. Arch Surg. Vol.125, No.5, pp.578-582
Ferrero JM., Namer M., (1994) Epidemiology of cancer of the breast.
Arch. Anat. Cytol. Pathol. Vol.42, No.5, pp.198-205
Folkman Judah, Shing Y. (1992) Angiogenesis, The journal of biological
Fontan PA., Amura CR., Sordelli DO. (1992) Treatment with a non-steroidal anti-inflammatory agent delays the growth of spontaneous pulmonary metastases of a mammary adenocarcinoma of non-detected immunogenicity. Br J cancer. Vol.66, No.5, pp.800-804
Fox SB., Turner GD., Gatter KC., Harris AL. (1995) The increased expression of adhesion molecules ICAM-3, E- and P-selectins on breast cancer endothelium. J pathol. Vol.177, No.4, pp.369-376
Gasparini Giampietro (2001) Clinical significance of determination of surrogate markers of angiogenesis in breast cancer. Critical Reviews in
Oncology/Hematology. Vol.37, pp.97-114
Giordano Sharon H., Hortobagyi G. N. (2003) Inflammatory breast cancer: Clinical progress and the main problems that must be addressed.
Breast cancer research Vol.5, No.6, pp.284-288
Glass JL., Frazee RC., (1995) Inflammatory breast cancer. Am Surg. Vol.61, No.2, pp.121-124
Günhan-Bilgen, Üstün Esin Emin, Memis Aysenur (2002) Inflammatory breast carcinoma: mammographic, ultrasonographic, clinical, and pathologic findings in 142 cases. Radiology. Vol.223, pp.829-838
Hance Kenneth W., Anderson W. F., Devesa S. S., Young Heather A., Levine P. H. (2005) Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the national cancer institute. Journal of the National Cancer Institute. Vol. 97, No.13, pp.966-975
Jussila L., Alitalo K. (2002) Vascular growth factors and lymphangiogenesis. Physiolol. Rev. Vol.82, No.3, pp.673-700
Kanae Y., Daiji E., Hiroshi Y., Hiroyuki T., Masanobu H. (2006) Expression of the PTEN tumor suppressor gene in malignant mammary gland tumors of dog. AJVR. Vol.67, No.1, pp.127-133
Kelsey Jennifer L., Berkowitz Gertrud S. (1998) Breast cancer epidemiology. Cancer research. Vol.48, pp.5615-5623
Kleer Celina G., Merajver Sofia D., Zang Y., Quinting Pan, Gallagher G., Wu Mei, Wu Zhi-Fen, (2004) WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer.
Breast cancer res. Vol.6, No.2, pp.R110-R115
Kleer Celina G., Kennet L. Van Golen, Merajver Sofia D. (2000) Molecolar biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinans. Breast cancer Res. Vol.2, pp.423-429
Kostopoulos I., Arapantoni-Dadioti P., Gogas H., Papadopoulos S., Malamou-Mitsi V., Scopa CD., Markaki S., Karagianni E., Kyriakou V., Margariti A., Kyrkou E., Pavlakis K., Zaramboukas T., Skordalaki A., Bourli A., Markopoulos C., Pectasides D., Dimopoulos MA., Skarlos D., Fountzilas G. (2006) Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy. Breast Cancer
Res Treat. Vol.96, No.3, pp.251-261
Kushwaha A. C., Whitman G. J., Stelling C. B., Cristofanilli M., Buzdar A. U. (2000) Primary inflammatory carcinoma of the breast.
American journal of roentgenology. Vol.174, pp.535-538
Lana Susan E., Rutteman Gerard R., Withrow Stephen J. (2001) Tumors of the mammary gland. Small animal clinical oncology. Cap.26 pp.619-633
Lazaris AC., Theodoropoulos GE., Diamantopoulos AK., Anastassopoulos PD., Davaris PS. (1997) Immunihistochemical detection of cathepsin D in low grade breast invasive cancer. Anticancer res. Vol.17, No.4A, pp.2651-2655
Lee AH., Dublin EA., Bobrow LG. (1999) Angiogenesis and expression of thymidine phosphorylase by inflammatory and carcinoma cell in ductal carcinoma in situ of the breast. J Pathol. Vol.187, No.3, pp.285-290
Lee A.H.S., Happerfield L. C., Bobrow L. G., Millis R. R. (1997) Angiogenesis and inflammation in invasive carcinoma of the breast. J.
Clin. Pathol. Vol.50, pp.669-673
Lee AH., Happerfield L. C., Bobrow L. G., Millis R. R. (1996) Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast. Br J cancer. Vol.74, No.5, pp.796-801
Leek D. Russel, Lewis Claire E., Ruth Whitehouse, Greenall M., Jane Clarke, Harris Adrian L. (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer
research. Vol.56, pp.4625-4629
Marconato Laura, Del Piero F. (2005) Oncologia medica dei piccoli
animali. cap.22, pp.440-456, cap.1, pp.7-11, cap.11, pp.156-158
Mariani-Costantini R., Colnaghi MI., Leoni F., Menard S., Cerasoli S., Rilke F. (1984) Immunohistochemical reactivity of a monoclonal antibody prepared against human breast carcinoma. Virchows Arch a pathol anat
histopathol. Vol.402, No.4, pp.389-404
Masakazu Toi, Kazuo Inada, Suzuki Hideo, Tominaga Takeshi (1995) Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast cancer research and treatment. Vol.36, pp.193-204
Max R., Gerritsen RR., Nooijen PT., Goodman SL., Keilholz U., Ruiter DJ., De Waal RM. (1997) Immunohistochemical analysis of integrin alpha vbeta3 expressio on tumor associated vessels of human carcinomas. Int J
McCarthy N. J., Xiaowei Y., Linnoila I. R., Merino M. J., Hewitt S. M., Parr A. L., Paik S., Steinberg S. M., Hartmann D. P., Mourali N., Levine P. H., Swain S. M. (2002) Microvessel density, expression of estrogen receptor α, MIB-1, p53 and c-erbB-2 in inflammatory breast cancer. Clinical cancer research. Vol.8, pp. 3857-3862
McGovern V. J., Shaw H. M., Milton G. W., McCarty W. H. (1982) Ulceration and prognosis cutaneous malignant melanoma. Histopahology. Vol.6, pp.399-407
McGuire WL., (1991) Breast Cancer Prognostic Factors Evaluation Guidelines. J. Natl. Cancer Inst. Vol.83, pp.154-155
Millanta F., Lazzeri G., Mazzei M., Vannozzi I., Poli A. (2002) MIB-1 labeling index in feline dysplastic and neoplastic mammary lesions and its relationship with postsurgical prognosis. Vet. Pathol. Vol.39, pp.120-126 Millanta F., Lazzeri G., Vannozzi I., Poli A., Viacava P. (2002) Correlation of vascular endothelial growth factor expression to overall survival in feline invasive mammary carcinomas. Vet. Pathol. Vol.39, pp.690-696
Millanta F., Calandrella M., Citi S., Della Santa D., Poli A. (2005) Overexpression of HER-2 in feline invasive mammary carcinomas: An immunohistochemical survey and evaluation of its prognostic potential.
Vet. Pathol. Vol.42, pp.30-34
Millanta F., Calandrella M., Vannozzi I., Poli A., Bari G., Niccolini M. (2005) Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues. Research in veterinary
Science. Vol.79, pp.225-232
Millanta F., S. Citi, D. Della Santa, M. Porciani, A. Poli (2006) COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic molecular markers. Breast
Misdorp W., Else R. W., Hellmén E., Lipscomb T. P. (1999) Histological classification of mammary tumors of the dog and the cat.
Mogavero GT., Fishman EK., Kuhlman JE. (1992) Inflammatory breast cancer: CT evaluation. Clin Imaging. Vol.16, No.3, pp.183-186
Nelson, Couto (2002) Medicina interna del cane e del gatto.
Nerurkar VR, Seshadri R, Mulherkar R, Ishwad CS, Lalitha VS, Naik SN (1987) Receptors for epidermal growth factor and estradiol in canine mammary tumors.Int J Cancer.Vol.40, No.2, pp.230-232
Owen LN., (1979) A comparative study of canine and human breast cancer. Vol.2, No.4, pp.257-275
Palombella D. I marcatori tumorali nel cancro della mammella: ruolo ed utilizzo.
http://web.mac.com/sims.sims/iWeb/Tumori%20del%20Seno/Marcatori.ht ml.
Parton M., Dowsett M., Ashley S., Hillis M., Lowe F., Smith I. E. (2003) High incidence of HER-2 positivity in inflammatory breast cancer.
The breast. Vol.13, pp.97-103
Peek U. (1988) Inflammatory breast carcinoma- possibilities and results of surgical treatment and adjuvant chemotherapy, especially when done preoperatively. Arch Geschwulstforsch. Vol.58, No.4, pp.275-285
Pérez Alenza Maria Dolores, Peña L., Nieto A., Jiménez, D. (2004) First description of feline inflammatory mammary carcinoma: clinicopathological and immunohistochemical characterstics of three cases.
Pérez Alenza Maria Dolores, Peña L., Nieto A., Castaño M. (1997) Clinical and pathological prognostic factors in canine mammary tumors.
Ann. Ist. Super. Sanità, Vol.33, No.4, pp.581-585
Pérez Alenza Maria Dolores, Peña L., Nieto A., Silván Gema, Illera Juan C. (2003) Steroid hormone profile of canine inflammatory mammary carcinoma: a preliminary study. The journal of steroid biochemistry and
molecular biology. Vol.84, pp.211-216
Pérez Alenza Maria Dolores, Peña L., Nieto A., Castaño M., M. A. Sánchez, J. M. Flores (2000) Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: clinical and pathologic association and prognostic significance. Vet pathol. Vol.37, pp.239-247 Pérez J., Ginel P. J., Lucena R., Mozos E. (2000) Vesiculopustular dermatitis associated with cutaneous metastases of an inflammatory mammary carcinosarcoma in a bitch. Veterinary record. Vol.147, pp.550-552
Pérez Alenza Maria Dolores, Peña L., Nieto A., Del Castillo N. (2000) Factors influencing the incidence and prognosis of canine mammary tumors. Journal of small animal practice. Vol.41, pp.287-291
Pérez Alenza Maria Dolores, Peña L., Nieto A., Rodriguez-Bertos A. (2003) Canine inflammatory mammary carcinoma: histopathology, immunoistochemistry and clinical implication of 21 cases. Breast cancer
res. Treat. Vol.78, No.2, pp.141-148
Pérez Alenza Maria Dolores, Peña L., E. Tabanera (2001) Inflammatory mammary carcinoma in dogs: 33 cases (1995-1999). J. Am. Vet. Med.
Assoc. Vol.219, pp.1110-1114
Pérez Alenza Maria Dolores, Peña L., Silván Gema, Illera Juan C., Lopes Carlos, Queiroga F. L. (2005) COX-2 levels in canine mammary tumors, including inflammatory mammary carcinoma: clinicopathological features and prognostic significance. Anticancer res. Vol.25, pp.4269-4276
Peters KG., Coogan A., Berry D., Marks J., Iglehart JD., Kontos CD., Rao P., Sankar S., Trogan E. (1998) Expression of Tie2/Tek in breast tumor vasculature provides a new marker for evaluation of tumour angiogenesis. Br J Cancer. Vol.77, No.1, pp.51-56
Robertson J.F.R., Blamey R.W. (2003) The use of gonadotrophin-releasing hormone (GnRH) agonists in early and advanced breast cancer in pre- and perimenopausal women. European Journal of Cancer. Vol.39, pp.861-869
Rutteman G. R., Foekens, J. A. Blankstain, M. A., Vos, J. H. Misdorp, (1990) EGF receptors in non affected and tumors dog mammary tissues.
European Journal of Cancer. Vol.26, pp.182-186
Sánchez-Archidona Ana R., M. A. Jiménez, D., Pérez-Alenza, Gema Silván, Juan C. Illera, L. Pẽna, Susana Dunner (2007) Steroid pathway and oestrone sulphate production in canine inflammatory mammary carcinoma. The journal of steroid biochemistry and molecular biology. Vol.104, pp.93-99
Sarli Giuseppe, Preziosi Rosario, Benazzi Cinzia, Castellani Gastone, Marcato Paolo Stefano (2002) Prognostic value of histologic stage and proliferative activity in canine malignant mammary tumors. J Vet
Diagn.Invest. Vol.14, pp.25-34
Shirakawa K., Furuhata S., Watanabe I., Hayase H., Shimizu A., Ikarashi Y., Yoshida T., Terada M., Hashimoto D., Wakasugi H. (2002) Induction of vasculogenesis in breast cancer models. BR J Cancer. Vol.87, No.12, pp.1454-1461
Slamon DJ, Clark GM, Wong SG, et al., (1987) Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Human breast
Sonnenschein E. G., Glickman L. T., Goldschmidt, M. H. Mckee (1991) Body conformation, diet, and risk of breast cancer in pet dogs: a case control stud. American Journal of epidemiology. Vol. 133, pp.694-703 Sunderkötter Cord, Steinbrink Kerstin, Goebeler M., Bhardwaj Ranjit, Sorg Clemens (1994) Macrophages and angiogenesis. Journal of
leukocyte biology. Vol.55, pp.410-422
Suzuki T., Inoue S., Kawabata W., Akahira J., Moriya T., Tsuchiya F., Ogawa S., Muramatsu M., Sasano H. (2001) EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine immune interactions. Br J
Cancer. Vol.85,No.11, pp. 1731-1737
Van der Auwera Ilse, Van Laere Steven J., Van den Eynden Gert G., Benoy Ina, Van Dam Peter, Colpaert Cecile G., Fox Sthephen B., Turley Helen, Harris Adrian L., Van Marck Eric A., Vermeulen Peter B., Dirix Luc Y. (2004) Increased angiogenesis and lymphangiogenesis in inflammatory versus non-inflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification. Clinical cancer
research. Vol.10, pp.7965-7971
Van Golen KL., Bao L., Di Vito MM., Wu Z., Prendergast GC., Merajver SD. (2002) Reversion of RhoC GTPase-induced inflammatory breast cancer phenotype by treatment with a farnesyl transferase inhibitor.
Mol. Cancer Ther. Vol.1, No.8, pp.575-583
Van Golen KL., Bao L., Pan Q., Miller FR., Wu Z., Merajver SD. (2002) Mitogen activated protein Kinase pathway is involved in RhoC GTPase-induced motility, invasion and angiogenesis in inflammatory breast cancer. Clin. Exp metastasis. Vol.19, No.4, pp.301-311
Vatten L., (1998) Female sex hormones increase the risk of breast cancer.
Tidsskr Nor. Laegeforen. Vol.118, No.19, pp.2969-2974 Norvegian
Verheul HA., Coelingh-Bennink HJ., Kenemans P., Atsma WJ., Burger CW., Eden JA., Hammar M., Marsden J., Purdie DW (2000)
Effect of estrogen and hormone replacement therapy on breast cancer risk and on efficacy of breast cancer therapies. Maturitas. Vol.36, No.1, pp.1-17 World congress- Vancouver 2001. World small animal veterinary association. Prognostic factors for canine and feline mammary cancer.
www.marvistavet.com/html/bodymammarytumorscanine.html
Yeh Lih- Seng, Lee Jia-Lin, Chen CM, Chang PH. (1999) Case report: a rare case of canine inflammatory mammary carcinoma. J Chin Soc Vet Sci. Vol.25, No.4, pp. 309-315
27 Wsava congress. Serum hormone profile of canine inflammatory carcinoma.
